Clinical Trials Logo

Postoperative Depression clinical trials

View clinical trials related to Postoperative Depression.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05233566 Completed - Clinical trials for Postoperative Depression

Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial

K-PASS
Start date: April 25, 2022
Phase: Phase 3
Study type: Interventional

This protocol describes a feasibility trial that will evaluate the feasibility of conducting a full-scale phase 3 trial testing the hypothesis that a postoperative sustained, low-dose ketamine infusion can prevent postoperative depressive symptoms when administered to a targeted population of neurosurgical patients with a history of depression.

NCT ID: NCT02452060 Completed - Pain Clinical Trials

Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy

Start date: October 2014
Phase: Phase 2/Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, two-arm parallel, single-center study. One hundred subjects (50 in each arm) will be enrolled. Subjects, between the ages 18 and 65, undergoing laparoscopic gastric bypass or sleeve gastrectomy will be recruited and consented during the preadmission visit prior to surgery.